The rebrand reflects Microbiome Labs' growth as a leader in microbiome science and creates a more unified brand system across ...
AbbVie and Genmab’s bispecific antibody blew analyst expectations out of the water with a 51% improvement in progression-free survival when used alongside a standard frontline regimen in diffuse large ...
Former senior Biogen and Roche executive brings deep experience across Alzheimer’s clinical development, launch readiness, ...
SCY-770 was well tolerated with a favorable safety profile in healthy adult participants at higher doses than previously ...
Leading Clinical Stage Oncology Company Releases Significant Findings from OST-HER2-Treated Patients
Leading Clinical Stage Oncology Company Releases Significant Findings from OST-HER2-Treated Patients. 72.7 percent three-year ...
Introduced by Smith+Nephew in the US during 2024, the CARTIHEAL Implant is rapidly transforming the cartilage repair ...
ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target. Cancer ...
WO 2026/178627 covers methods, uses and compositions pairing Streptococcus salivarius SALI-10 with sorbitol, creating a ...
Dr. Meltzer joins Avilar as the company advances its lead ATAC program toward the clinic. The program is an ATAC designed to ...
CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more ...
FDA clearance of its Investigational New Drug (IND) application for MC001, the Company's first-in-class dimeric ...
Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results